| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Investing > Why Invest in New Zealand Apartment Now? |
|
Top Adding - Why Invest in New Zealand Apartment Now?
There is no doubt that every investment is about getting the good return in the future, just like planting an apple tree t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product oday and hopefully to enjoy fruit tomorrow. Some investments get excellent return while others get none or little. So choo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ing an investment which has great future return is every investor’s goal. New Zealand is a small country in the Australas lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a region. Current population is about 4.15 million. 1.24 million people live in Auckland – the largest city in New Zealand here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe New Zealand’s efficient, market-driven economy delivers key benefits to investors, including: (1) Business stability (2)E d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tensive free-trade agreements (3)Active government support for investment. The property market in New Zealand is growing ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc trongly. Auckland city apartment is the biggest apartment market in New Zealand. It has about 13,500 apartment units in Au easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi kland CBD area. Overall apartment price has been flatted due to over supply since year 2004. So Why it is Wise to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Invest in New Zealand Apartment especially Auckland City Apartment Now? (1) It is easy to achieve high and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ental yields. For example, a small studio at Auckland Central City costing about NZ $ 120,000 can normally rent o ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t as $230 to $250 per week (depends on the location and facility it has). (2) New Zealand apartment has big growt ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a potential in the near future. The recent Auckland city council’s plans to increase levy substantially has huge i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod pact on the future development of new apartment buildings (source: New Zealand Herald, 28 Feb 2007). This is potentially g cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin od news for existing apartment owners. If the city council’s proposals takes effect on the 1st of July 2007, huge increasi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen g levies will force developer to get out of the city apartment market therefore limited supply will push the city apartmen t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel price up. (3) Affordability - The starting price is around NZ $110,000 – 120,000. The current market pr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ce is already a big discount than 3 years ago. (4) No Stamp Duty - There is no stamp duty to pay on prop y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rty purchase in New Zealand. Every investment has its risk. It is hard to make a good investment decision without sound k . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de owledge and understanding of the local property market. To minimise the risk of investing in New Zealand apartment you nee elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip an apartment specialist who has the local knowledge and experience to help you find the right property at the right price tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Generating Sales Leads in the Construction Industry
|